Beihai Gofar Marine Biological Industry Co Ltd Cash Flow Conversion Efficiency
Beihai Gofar Marine Biological Industry Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.30 Million ≈ $-1.51 Million USD) by net assets (CN¥785.32 Million ≈ $114.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Beihai Gofar Marine Biological Industry Co Ltd (2001–2025)
Cash flow conversion efficiency of Beihai Gofar Marine Biological Industry Co Ltd from 2001 to 2025. This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600538 stock price for real-time trading data and today's change.
Beihai Gofar Marine Biological Industry Co Ltd Cash Flow Conversion Ratio Explained
Beihai Gofar Marine Biological Industry Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their cash flow conversion efficiency. Also see 600538 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Suzhou Yangtze New Materials
SHE:002652
|
0.025x |
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
-0.099x |
|
Norske Skog Asa
OL:NSKOG
|
-0.052x |
|
Eightco Holdings Inc.
NASDAQ:ORBS
|
-0.013x |
|
Agencia Comercial Spirits Ltd Class A Ordinary Shares
NASDAQ:AGCC
|
N/A |
|
Materialise NV
NASDAQ:MTLS
|
0.027x |
|
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN
|
-0.139x |
|
Ningbo Color Master Batch Co. Ltd.
SHE:301019
|
0.030x |
Annual Cash Flow Conversion Efficiency for Beihai Gofar Marine Biological Industry Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Beihai Gofar Marine Biological Industry Co Ltd from 2001 to 2025. Review 600538 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥700.78 Million ≈ $102.55 Million |
CN¥-13.40 Million ≈ $-1.96 Million |
-0.019x | -872.57% |
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
CN¥1.95 Million ≈ $285.10K |
0.002x | +112.11% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
CN¥-17.97 Million ≈ $-2.63 Million |
-0.020x | -24.61% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
CN¥-15.74 Million ≈ $-2.30 Million |
-0.016x | -138.70% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
CN¥-6.34 Million ≈ $-927.46K |
-0.007x | -121.79% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
CN¥26.84 Million ≈ $3.93 Million |
0.032x | +473.92% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
CN¥-5.44 Million ≈ $-796.48K |
-0.008x | +84.07% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
CN¥-33.75 Million ≈ $-4.94 Million |
-0.053x | -196.61% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥36.12 Million ≈ $5.29 Million |
0.055x | +302.99% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.027x | -204.70% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
CN¥-6.54 Million ≈ $-956.52K |
-0.009x | +84.25% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
CN¥-41.05 Million ≈ $-6.01 Million |
-0.056x | -26.81% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
CN¥-4.95 Million ≈ $-724.11K |
-0.044x | +83.13% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
CN¥-24.09 Million ≈ $-3.52 Million |
-0.263x | -215.90% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
CN¥-15.95 Million ≈ $-2.33 Million |
-0.083x | -27.56% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
CN¥-14.71 Million ≈ $-2.15 Million |
-0.065x | -514.62% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
CN¥-2.20 Million ≈ $-322.18K |
-0.011x | -119.93% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
CN¥17.34 Million ≈ $2.54 Million |
0.053x | -38.36% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
CN¥42.60 Million ≈ $6.23 Million |
0.086x | -51.04% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
CN¥93.45 Million ≈ $13.67 Million |
0.177x | +3215.25% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
CN¥2.94 Million ≈ $429.53K |
0.005x | -53.20% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
CN¥5.94 Million ≈ $869.21K |
0.011x | +1364.46% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
CN¥-430.83K ≈ $-63.04K |
-0.001x | -100.78% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
CN¥17.01 Million ≈ $2.49 Million |
0.115x | -35.72% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
CN¥23.35 Million ≈ $3.42 Million |
0.179x | -- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, phar… Read more